The Failure of “Vaccine Passports”

DEBATES ON COVID - VACCINES, 12 Jul 2021

Swiss Policy Research - TRANSCEND Media Service

With vaccine effectiveness down to just 60%, the case for “vaccine passports” implodes.

5 Jul 2021 – SPR and some other independent expert groups warned very early on that “vaccine passports” – promoted by Bill Gates and his ID2020 alliance – are doomed to fail (from a medical perspective), simply because covid vaccines cannot achieve sterilizing immunity (i.e. prevent infection and infectiousness), especially not against new coronavirus variants.

New data from Israel now confirms that the effectiveness of mRNA vaccines against infection and even against mild symptoms caused by the Indian variant has already dropped to just 64%, while effectiveness against severe disease remains above 90%. The effectiveness of DNA adenovector vaccines like AstraZeneca is likely already below 60% (against infections).

In a particularly impressive case, a vaccinated Israeli caught the Indian variant in London, infected another vaccinated person in Israel, who infected another vaccinated person, who infected about 80 students at a high school party. In all likelihood, most of these transmissions occurred pre-symptomatically, i.e. without people knowing they were infected and infectious.

As the above map shows, many US states have already banned “vaccine passports”, though people may still require them for international travel. In the UK, the situation remains somewhat uncertain, whereas the EU and several Asian countries remain determined to implement their “vaccine passport” schemes. Israel phased out its “green pass” in June, but there are talks of “reactivating” it.

After face masks, lockdowns and “contact tracing apps” (inserted into three billion mobile phones by Google and Apple), “vaccine passports” are yet another major “failure” in the international response to the coronavirus pandemic. Instead, the goal should be to achieve vaccine protection against severe disease in the high-risk group, avoid vaccine casualties in the low-risk group, and make progress in the research and use of effective and affordable early treatment options.

See also:

• Facts about Covid-19
• Covid: Global Mortality
• Covid: A “Strange Pandemic”

__________________________________________

Swiss Policy Research, founded in 2016, is an independent, nonpartisan and nonprofit research group investigating geopolitical propaganda in Swiss and international media. SPR is composed of independent academics that for personal and professional reasons prefer to protect their identities, and receives no external funding; there are no financial sponsors or backers. Our articles have been published or shared by numerous independent media outlets and journalists, among them Julian Assange, and have been translated into more than two dozen languages.

Go to Original – swprs.org

Share this article: email mastodon facebook 🔗 copy link

DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.

Comments are closed.